{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T15:22:40Z","timestamp":1785770560301,"version":"3.56.0"},"reference-count":75,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2023,7,10]],"date-time":"2023-07-10T00:00:00Z","timestamp":1688947200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,7,10]],"date-time":"2023-07-10T00:00:00Z","timestamp":1688947200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Neurosci"],"published-print":{"date-parts":[[2023,8]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The Dominantly Inherited Alzheimer Network (DIAN) is an international collaboration studying autosomal dominant Alzheimer disease (ADAD). ADAD arises from mutations occurring in three genes. Offspring from ADAD families have a 50% chance of inheriting their familial mutation, so non-carrier siblings can be recruited for comparisons in case\u2013control studies. The age of onset in ADAD is highly predictable within families, allowing researchers to estimate an individual\u2019s point in the disease trajectory. These characteristics allow candidate AD biomarker measurements to be reliably mapped during the preclinical phase. Although ADAD represents a small proportion of AD cases, understanding neuroimaging-based changes that occur during the preclinical period may provide insight into early disease stages of \u2018sporadic\u2019 AD also. Additionally, this study provides rich data for research in healthy aging through inclusion of the non-carrier controls. Here we introduce the neuroimaging dataset collected and describe how this resource can be used by a range of researchers.<\/jats:p>","DOI":"10.1038\/s41593-023-01359-8","type":"journal-article","created":{"date-parts":[[2023,7,10]],"date-time":"2023-07-10T16:03:06Z","timestamp":1689004986000},"page":"1449-1460","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":41,"title":["Positron emission tomography and magnetic resonance imaging methods and datasets within the Dominantly Inherited Alzheimer Network (DIAN)"],"prefix":"10.1038","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4123-2548","authenticated-orcid":false,"given":"Nicole S.","family":"McKay","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2109-2955","authenticated-orcid":false,"given":"Brian A.","family":"Gordon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Russ C.","family":"Hornbeck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aylin","family":"Dincer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2726-8704","authenticated-orcid":false,"given":"Shaney","family":"Flores","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah J.","family":"Keefe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9735-5152","authenticated-orcid":false,"given":"Nelly","family":"Joseph-Mathurin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7916-622X","authenticated-orcid":false,"given":"Clifford R.","family":"Jack","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Koeppe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4588-739X","authenticated-orcid":false,"given":"Peter R.","family":"Millar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beau M.","family":"Ances","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6698-1268","authenticated-orcid":false,"given":"Charles D.","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alisha","family":"Daniels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7822-6411","authenticated-orcid":false,"given":"Diana A.","family":"Hobbs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelley","family":"Jackson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah","family":"Koudelis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parinaz","family":"Massoumzadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Austin","family":"McCullough","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael L.","family":"Nickels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farzaneh","family":"Rahmani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Swisher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7166-1234","authenticated-orcid":false,"given":"Ricardo F.","family":"Allegri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah B.","family":"Berman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam M.","family":"Brickman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8603-4233","authenticated-orcid":false,"given":"William S.","family":"Brooks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7833-616X","authenticated-orcid":false,"given":"David M.","family":"Cash","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7792-1698","authenticated-orcid":false,"given":"Jasmeer P.","family":"Chhatwal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5133-5538","authenticated-orcid":false,"given":"Gregory S.","family":"Day","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin R.","family":"Farlow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7519-0417","authenticated-orcid":false,"given":"Christian","family":"la Foug\u00e8re","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nick C.","family":"Fox","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0602-6319","authenticated-orcid":false,"given":"Michael","family":"Fulham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1842-8019","authenticated-orcid":false,"given":"Bernardino","family":"Ghetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neill","family":"Graff-Radford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8828-8085","authenticated-orcid":false,"given":"Takeshi","family":"Ikeuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Klunk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jae-Hong","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes","family":"Levin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ralph","family":"Martins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colin L.","family":"Masters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"McConathy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Mori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James M.","family":"Noble","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerald","family":"Reischl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Rowe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2631-0942","authenticated-orcid":false,"given":"Stephen","family":"Salloway","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raquel","family":"Sanchez-Valle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2967-9662","authenticated-orcid":false,"given":"Peter R.","family":"Schofield","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyuki","family":"Shimada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mikio","family":"Shoji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1946-8063","authenticated-orcid":false,"given":"Yi","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazushi","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5965-838X","authenticated-orcid":false,"given":"Jonathan","family":"V\u00f6glein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Igor","family":"Yakushev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0276-2899","authenticated-orcid":false,"given":"Carlos","family":"Cruchaga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason","family":"Hassenstab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6854-5547","authenticated-orcid":false,"given":"Celeste","family":"Karch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6764-3866","authenticated-orcid":false,"given":"Eric","family":"McDade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3443-7716","authenticated-orcid":false,"given":"Richard J.","family":"Perrin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengjie","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John C.","family":"Morris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7729-1702","authenticated-orcid":false,"given":"Randall J.","family":"Bateman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8114-0552","authenticated-orcid":false,"given":"Tammie L. S.","family":"Benzinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"the Dominantly Inherited Alzheimer Network","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam. M.","family":"Brickman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"la Foug\u00e8re","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,7,10]]},"reference":[{"key":"1359_CR1","doi-asserted-by":"crossref","first-page":"1968","DOI":"10.1016\/S0140-6736(13)62426-5","volume":"382","author":"NC Fox","year":"2013","unstructured":"Fox, N. C. & Petersen, R. C. The G8 Dementia Research Summit\u2014a starter for eight? Lancet 382, 1968\u20131969 (2013).","journal-title":"Lancet"},{"key":"1359_CR2","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/j.nic.2005.09.008","volume":"15","author":"SG Mueller","year":"2005","unstructured":"Mueller, S. G. et al. The Alzheimer\u2019s disease neuroimaging initiative. Neuroimaging Clin. N. Am. 15, 869\u2013877 (2005).","journal-title":"Neuroimaging Clin. N. Am."},{"key":"1359_CR3","doi-asserted-by":"crossref","unstructured":"Ellis, K. A. et al. The Australian Imaging, Biomarkers and Lifestyle (AIBL) study of aging: methodology and baseline characteristics of 1112 individuals recruited for a longitudinal study of Alzheimer\u2019s disease. Int. Psychogeriatr. 21, 672\u2013687 (2009).","DOI":"10.1017\/S1041610209009405"},{"key":"1359_CR4","doi-asserted-by":"crossref","first-page":"975","DOI":"10.4155\/cli.12.93","volume":"2","author":"JC Morris","year":"2012","unstructured":"Morris, J. C. et al. Developing an international network for Alzheimer research: the Dominantly Inherited Alzheimer Network. Clin. Investig. (Lond). 2, 975\u2013984 (2012).","journal-title":"Clin. Investig. (Lond)."},{"key":"1359_CR5","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1056\/NEJMoa1202753","volume":"367","author":"RJ Bateman","year":"2012","unstructured":"Bateman, R. J. et al. Clinical and biomarker changes in dominantly inherited Alzheimer\u2019s disease. N. Engl. J. Med. 367, 795\u2013804 (2012).","journal-title":"N. Engl. J. Med."},{"key":"1359_CR6","doi-asserted-by":"crossref","unstructured":"Cruchaga, C., Chakraverty, S., Mayo, K. & Vallania, F. L. M. Rare variants in APP, PSEN1 and PSEN2 increase risk for AD in late-onset Alzheimer\u2019s disease families. PLoS ONE 7, e31039 (2012).","DOI":"10.1371\/journal.pone.0031039"},{"key":"1359_CR7","doi-asserted-by":"crossref","first-page":"5481","DOI":"10.1038\/s41380-021-01249-0","volume":"26","author":"H Hampel","year":"2021","unstructured":"Hampel, H. et al. The amyloid-\u03b2 pathway in Alzheimer\u2019s disease. Mol. Psychiatry 26, 5481\u20135503 (2021).","journal-title":"Mol. Psychiatry"},{"key":"1359_CR8","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1212\/WNL.0000000000000596","volume":"83","author":"DC Ryman","year":"2014","unstructured":"Ryman, D. C. et al. Symptom onset in autosomal dominant Alzheimer disease: a systematic review and meta-analysis. Neurology 83, 253\u2013260 (2014).","journal-title":"Neurology"},{"key":"1359_CR9","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1007\/s00401-021-02342-y","volume":"142","author":"CD Chen","year":"2021","unstructured":"Chen, C. D. et al. Comparing amyloid-\u03b2 plaque burden with antemortem PiB PET in autosomal dominant and late-onset Alzheimer disease. Acta Neuropathol. 142, 689\u2013706 (2021).","journal-title":"Acta Neuropathol."},{"key":"1359_CR10","doi-asserted-by":"crossref","unstructured":"Chen, C. D. et al. Ante- and postmortem tau in autosomal dominant and late-onset Alzheimer\u2019s disease. Ann. Clin. Transl. Neurol. 7, 2475\u20132480 (2020).","DOI":"10.1002\/acn3.51237"},{"key":"1359_CR11","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1038\/s41591-021-01369-8","volume":"27","author":"S Salloway","year":"2021","unstructured":"Salloway, S. et al. A trial of gantenerumab or solanezumab in dominantly inherited Alzheimer\u2019s disease. Nat. Med. 27, 1187\u20131196 (2021).","journal-title":"Nat. Med."},{"key":"1359_CR12","doi-asserted-by":"crossref","unstructured":"Morris, J. C. et al. Autosomal dominant and sporadic late onset Alzheimer disease share a common in vivo pathophysiology. Brain 145, 3594\u20133607 (2022).","DOI":"10.1093\/brain\/awac181"},{"key":"1359_CR13","first-page":"E4502","volume":"110","author":"TLS Benzinger","year":"2013","unstructured":"Benzinger, T. L. S. et al. Regional variability of imaging biomarkers in autosomal dominant Alzheimer\u2019s disease. Proc. Natl Acad. Sci. USA 110, E4502\u2013E4509 (2013).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1359_CR14","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1093\/brain\/awz019","volume":"142","author":"BA Gordon","year":"2019","unstructured":"Gordon, B. A. et al. Tau PET in autosomal dominant Alzheimer\u2019s disease: relationship with cognition, dementia and other biomarkers. Brain 142, 1063\u20131076 (2019).","journal-title":"Brain"},{"key":"1359_CR15","doi-asserted-by":"crossref","first-page":"e064684","DOI":"10.1002\/alz.064684","volume":"18","author":"A Boerwinkle","year":"2022","unstructured":"Boerwinkle, A. et al. Comparison of amyloid accumulation between Down syndrome and autosomal-dominant Alzheimer disease. Alzheimers Dement. 18, e064684 (2022).","journal-title":"Alzheimers Dement."},{"key":"1359_CR16","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S1474-4422(22)00408-2","volume":"22","author":"AH Boerwinkle","year":"2023","unstructured":"Boerwinkle, A. H. et al. Comparison of amyloid burden in individuals with Down syndrome versus autosomal dominant Alzheimer\u2019s disease: a cross-sectional study. Lancet Neurol. 22, 55\u201365 (2023).","journal-title":"Lancet Neurol."},{"key":"1359_CR17","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1006\/nbdi.1998.0202","volume":"5","author":"C De Jonghe","year":"1998","unstructured":"De Jonghe, C. et al. Flemish and Dutch mutations in amyloid \u03b2 precursor protein have different effects on amyloid \u03b2 secretion. Neurobiol. Dis. 5, 281\u2013286 (1998).","journal-title":"Neurobiol. Dis."},{"key":"1359_CR18","doi-asserted-by":"crossref","first-page":"2412","DOI":"10.1212\/WNL.43.1_Part_1.241-a","volume":"43","author":"JC Morris","year":"1993","unstructured":"Morris, J. C. The Clinical Dementia Rating (CDR): current version and scoring rules. Neurology 43, 2412\u20132414 (1993).","journal-title":"Neurology"},{"key":"1359_CR19","unstructured":"R Core Team. R: a language and environment for statistical computing. https:\/\/www.r-project.org\/ (R Foundation for Statistical Computing, 2019)."},{"key":"1359_CR20","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0022-3956(75)90026-6","volume":"12","author":"MF Folstein","year":"1975","unstructured":"Folstein, M. F., Folstein, S. E. & McHugh, P. R. \u2018Mini-mental state\u2019: a practical method for grading the cognitive state of patients for the clinician. J. Psychiatr. Res. 12, 189\u2013198 (1975).","journal-title":"J. Psychiatr. Res."},{"key":"1359_CR21","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/0361-476X(81)90035-7","volume":"6","author":"D Wechsler","year":"1981","unstructured":"Wechsler, D. The psychometric tradition: developing the Wechsler Adult Intelligence Scale. Contemp. Educ. Psychol. 6, 82\u201385 (1981).","journal-title":"Contemp. Educ. Psychol."},{"key":"1359_CR22","unstructured":"Wechsler, D. Wechsler Memory Scale 3rd edn (Pearson, 1997)."},{"key":"1359_CR23","unstructured":"Goodglass, H. & Kaplan, E. Boston Diagnostic Aphasia Examination (Lea & Febiger, 1983)."},{"key":"1359_CR24","doi-asserted-by":"crossref","first-page":"e73377","DOI":"10.1371\/journal.pone.0073377","volume":"8","author":"Y Su","year":"2013","unstructured":"Su, Y. et al. Quantitative analysis of PiB-PET with FreeSurfer ROIs. PLoS ONE 8, e73377 (2013).","journal-title":"PLoS ONE"},{"key":"1359_CR25","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/S0896-6273(02)00569-X","volume":"33","author":"B Fischl","year":"2002","unstructured":"Fischl, B. et al. Whole brain segmentation: automated labeling of neuroanatomical structures in the human brain. Neuron 33, 341\u2013355 (2002).","journal-title":"Neuron"},{"key":"1359_CR26","unstructured":"Dincer, A. et al. Comparing cortical signatures of atrophy between late-onset and autosomal dominant Alzheimer disease. Neuroimage Clin. 28, 102491 (2020)."},{"key":"1359_CR27","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/S1474-4422(21)00375-6","volume":"21","author":"JP Chhatwal","year":"2022","unstructured":"Chhatwal, J. P. et al. Variant-dependent heterogeneity in amyloid \u03b2 burden in autosomal dominant Alzheimer\u2019s disease: cross-sectional and longitudinal analyses of an observational study. Lancet Neurol. 21, 140\u2013152 (2022).","journal-title":"Lancet Neurol."},{"key":"1359_CR28","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1038\/s41582-019-0281-2","volume":"16","author":"SM Greenberg","year":"2020","unstructured":"Greenberg, S. M. et al. Cerebral amyloid angiopathy and Alzheimer disease\u2014one peptide, two pathways. Nat. Rev. Neurol. 16, 30\u201342 (2020).","journal-title":"Nat. Rev. Neurol."},{"key":"1359_CR29","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1038\/s41562-020-01005-4","volume":"5","author":"C Horien","year":"2021","unstructured":"Horien, C. et al. A hitchhiker\u2019s guide to working with large, open-source neuroimaging datasets. Nat. Hum. Behav. 5, 185\u2013193 (2021).","journal-title":"Nat. Hum. Behav."},{"key":"1359_CR30","doi-asserted-by":"crossref","first-page":"3251","DOI":"10.1073\/pnas.1815917116","volume":"116","author":"MS Goyal","year":"2019","unstructured":"Goyal, M. S. et al. Persistent metabolic youth in the aging female brain. Proc. Natl Acad. Sci. USA 116, 3251\u20133255 (2019).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1359_CR31","doi-asserted-by":"crossref","first-page":"102248","DOI":"10.1016\/j.nicl.2020.102248","volume":"26","author":"LN Koenig","year":"2020","unstructured":"Koenig, L. N. et al. Select atrophied regions in Alzheimer disease (SARA): an improved volumetric model for identifying Alzheimer disease dementia. Neuroimage Clin. 26, 102248 (2020).","journal-title":"Neuroimage Clin."},{"key":"1359_CR32","doi-asserted-by":"crossref","first-page":"119228","DOI":"10.1016\/j.neuroimage.2022.119228","volume":"256","author":"PR Millar","year":"2022","unstructured":"Millar, P. R. et al. Predicting brain age from functional connectivity in symptomatic and preclinical Alzheimer disease. Neuroimage 256, 119228 (2022).","journal-title":"Neuroimage"},{"key":"1359_CR33","doi-asserted-by":"crossref","first-page":"e81869","DOI":"10.7554\/eLife.81869","volume":"12","author":"PR Millar","year":"2023","unstructured":"Millar, P. R. et al. Multimodal brain age estimates relate to Alzheimer disease biomarkers and cognition in early stages: a cross-sectional observational study. Elife 12, e81869 (2023).","journal-title":"Elife"},{"key":"1359_CR34","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1038\/s41586-022-04554-y","volume":"604","author":"RAI Bethlehem","year":"2022","unstructured":"Bethlehem, R. A. I. et al. Brain charts for the human lifespan. Nature 604, 525\u2013533 (2022).","journal-title":"Nature"},{"key":"1359_CR35","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1038\/s41591-018-0304-3","volume":"25","author":"O Preische","year":"2019","unstructured":"Preische, O. et al. Serum neurofilament dynamics predicts neurodegeneration and clinical progression in presymptomatic Alzheimer\u2019s disease. Nat. Med. 25, 277\u2013283 (2019).","journal-title":"Nat. Med."},{"key":"1359_CR36","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1212\/WNL.0b013e3182a841c6","volume":"81","author":"DM Cash","year":"2013","unstructured":"Cash, D. M. et al. The pattern of atrophy in familial Alzheimer disease: volumetric MRI results from the DIAN study. Neurology 81, 1425\u20131433 (2013).","journal-title":"Neurology"},{"key":"1359_CR37","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S1474-4422(18)30028-0","volume":"17","author":"BA Gordon","year":"2018","unstructured":"Gordon, B. A. et al. Spatial patterns of neuroimaging biomarker change in individuals from families with autosomal dominant Alzheimer\u2019s disease: a longitudinal study. Lancet Neurol. 17, 241\u2013250 (2018).","journal-title":"Lancet Neurol."},{"key":"1359_CR38","doi-asserted-by":"crossref","first-page":"e0195838","DOI":"10.1371\/journal.pone.0195838","volume":"13","author":"S Lee","year":"2018","unstructured":"Lee, S. et al. White matter hyperintensities and the mediating role of cerebral amyloid angiopathy in dominantly-inherited Alzheimer\u2019s disease. PLoS ONE 13, e0195838 (2018).","journal-title":"PLoS ONE"},{"key":"1359_CR39","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1002\/ana.24647","volume":"79","author":"S Lee","year":"2016","unstructured":"Lee, S. et al. White matter hyperintensities are a core feature of Alzheimer\u2019s disease: evidence from the dominantly inherited Alzheimer network. Ann. Neurol. 79, 929\u2013939 (2016).","journal-title":"Ann. Neurol."},{"key":"1359_CR40","doi-asserted-by":"crossref","unstructured":"Joseph-Mathurin, N. et al. Longitudinal accumulation of cerebral microhemorrhages in dominantly inherited Alzheimer disease. Neurology 96, e1632\u2013e1645 (2021).","DOI":"10.1212\/WNL.0000000000011542"},{"key":"1359_CR41","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1111\/neup.12205","volume":"35","author":"NJ Cairns","year":"2015","unstructured":"Cairns, N. J. et al. Neuropathologic assessment of participants in two multi-center longitudinal observational studies: the Alzheimer Disease Neuroimaging Initiative (ADNI) and the Dominantly Inherited Alzheimer Network (DIAN). Neuropathology 35, 390\u2013400 (2015).","journal-title":"Neuropathology"},{"key":"1359_CR42","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1093\/brain\/awy053","volume":"141","author":"JP Chhatwal","year":"2018","unstructured":"Chhatwal, J. P. et al. Preferential degradation of cognitive networks differentiates Alzheimer\u2019s disease from ageing. Brain 141, 1486\u20131500 (2018).","journal-title":"Brain"},{"key":"1359_CR43","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1212\/WNL.0b013e3182a1aafe","volume":"81","author":"JP Chhatwal","year":"2013","unstructured":"Chhatwal, J. P. et al. Impaired default network functional connectivity in autosomal dominant Alzheimer disease. Neurology 81, 736\u2013744 (2013).","journal-title":"Neurology"},{"key":"1359_CR44","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1093\/brain\/awy008","volume":"141","author":"N Franzmeier","year":"2018","unstructured":"Franzmeier, N. et al. Left frontal hub connectivity delays cognitive impairment in autosomal-dominant and sporadic Alzheimer\u2019s disease. Brain 141, 1186\u20131200 (2018).","journal-title":"Brain"},{"key":"1359_CR45","doi-asserted-by":"crossref","unstructured":"Smith, R. et al. Resting-state functional connectivity disruption as a pathological biomarker in autosomal dominant Alzheimer disease. Brain Connect. 11, 239\u2013249 (2021).","DOI":"10.1089\/brain.2020.0808"},{"key":"1359_CR46","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/j.neurol.2013.07.017","volume":"169","author":"SM Mills","year":"2013","unstructured":"Mills, S. M. et al. Preclinical trials in autosomal dominant AD: implementation of the DIAN-TU trial. Rev. Neurol. 169, 737\u2013743 (2013).","journal-title":"Rev. Neurol."},{"key":"1359_CR47","doi-asserted-by":"crossref","first-page":"104960","DOI":"10.1016\/j.nbd.2020.104960","volume":"142","author":"SA Schultz","year":"2020","unstructured":"Schultz, S. A. et al. Serum neurofilament light chain levels are associated with white matter integrity in autosomal dominant Alzheimer\u2019s disease. Neurobiol. Dis. 142, 104960 (2020).","journal-title":"Neurobiol. Dis."},{"key":"1359_CR48","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/s13195-018-0400-0","volume":"10","author":"CM Karch","year":"2018","unstructured":"Karch, C. M. et al. Human fibroblast and stem cell resource from the Dominantly Inherited Alzheimer Network. Alzheimers Res. Ther. 10, 69 (2018).","journal-title":"Alzheimers Res. Ther."},{"key":"1359_CR49","doi-asserted-by":"crossref","first-page":"226ra30","DOI":"10.1126\/scitranslmed.3007901","volume":"6","author":"AM Fagan","year":"2014","unstructured":"Fagan, A. M. et al. Longitudinal change in CSF biomarkers in autosomal-dominant Alzheimer\u2019s disease. Sci. Transl. Med. 6, 226ra30 (2014).","journal-title":"Sci. Transl. Med."},{"key":"1359_CR50","doi-asserted-by":"crossref","first-page":"2123","DOI":"10.1016\/j.neuroimage.2009.11.006","volume":"49","author":"F Kruggel","year":"2010","unstructured":"Kruggel, F., Turner, J., Muftuler, L. T. & Alzheimer\u2019s Disease Neuroimaging Initiative. Impact of scanner hardware and imaging protocol on image quality and compartment volume precision in the ADNI cohort. Neuroimage 49, 2123\u20132133 (2010).","journal-title":"Neuroimage"},{"key":"1359_CR51","doi-asserted-by":"crossref","first-page":"117129","DOI":"10.1016\/j.neuroimage.2020.117129","volume":"220","author":"JC Beer","year":"2020","unstructured":"Beer, J. C. et al. Longitudinal ComBat: a method for harmonizing longitudinal multi-scanner imaging data. Neuroimage 220, 117129 (2020).","journal-title":"Neuroimage"},{"key":"1359_CR52","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1002\/jmri.21049","volume":"27","author":"CR Jack Jr","year":"2008","unstructured":"Jack, C. R. Jr et al. The Alzheimer\u2019s Disease Neuroimaging Initiative (ADNI): MRI methods. J. Magn. Reson. Imaging 27, 685\u2013691 (2008).","journal-title":"J. Magn. Reson. Imaging"},{"key":"1359_CR53","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/j.jalz.2015.05.001","volume":"11","author":"WJ Jagust","year":"2015","unstructured":"Jagust, W. J. et al. The Alzheimer\u2019s Disease Neuroimaging Initiative 2 PET Core: 2015. Alzheimers Dement. 11, 757\u2013771 (2015).","journal-title":"Alzheimers Dement."},{"key":"1359_CR54","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1093\/jnen\/nlv028","volume":"75","author":"JM Ringman","year":"2016","unstructured":"Ringman, J. M. et al. Neuropathology of autosomal dominant Alzheimer disease in the National Alzheimer Coordinating Center Database. J. Neuropathol. Exp. Neurol. 75, 284\u2013290 (2016).","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"1359_CR55","doi-asserted-by":"crossref","first-page":"fcaa102","DOI":"10.1093\/braincomms\/fcaa102","volume":"2","author":"L Vermunt","year":"2020","unstructured":"Vermunt, L. et al. Single-subject grey matter network trajectories over the disease course of autosomal dominant Alzheimer\u2019s disease. Brain Commun. 2, fcaa102 (2020).","journal-title":"Brain Commun."},{"key":"1359_CR56","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.neuron.2006.08.012","volume":"51","author":"S Mori","year":"2006","unstructured":"Mori, S. & Zhang, J. Principles of diffusion tensor imaging and its applications to basic neuroscience research. Neuron 51, 527\u2013539 (2006).","journal-title":"Neuron"},{"key":"1359_CR57","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1002\/mrm.1910360612","volume":"36","author":"C Pierpaoli","year":"1996","unstructured":"Pierpaoli, C. & Basser, P. J. Toward a quantitative assessment of diffusion anisotropy. Magn. Reson. Med. 36, 893\u2013906 (1996).","journal-title":"Magn. Reson. Med."},{"key":"1359_CR58","doi-asserted-by":"crossref","first-page":"101767","DOI":"10.1016\/j.nicl.2019.101767","volume":"22","author":"Q Wang","year":"2019","unstructured":"Wang, Q. et al. Quantification of white matter cellularity and damage in preclinical and early symptomatic Alzheimer\u2019s disease. Neuroimage Clin. 22, 101767 (2019).","journal-title":"Neuroimage Clin."},{"key":"1359_CR59","doi-asserted-by":"crossref","first-page":"2766","DOI":"10.1016\/j.neurobiolaging.2012.01.016","volume":"33","author":"T Grimmer","year":"2012","unstructured":"Grimmer, T. et al. White matter hyperintensities predict amyloid increase in Alzheimer\u2019s disease. Neurobiol. Aging 33, 2766\u20132773 (2012).","journal-title":"Neurobiol. Aging"},{"key":"1359_CR60","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1148\/rg.295095034","volume":"29","author":"GB Chavhan","year":"2009","unstructured":"Chavhan, G. B., Babyn, P. S., Thomas, B., Shroff, M. M. & Haacke, E. M. Principles, techniques, and applications of T2*-based MR imaging and its special applications. Radiographics 29, 1433\u20131449 (2009).","journal-title":"Radiographics"},{"key":"1359_CR61","doi-asserted-by":"crossref","first-page":"2483","DOI":"10.1093\/brain\/awz162","volume":"142","author":"J Graff-Radford","year":"2019","unstructured":"Graff-Radford, J. et al. White matter hyperintensities: relationship to amyloid and tau burden. Brain 142, 2483\u20132491 (2019).","journal-title":"Brain"},{"key":"1359_CR62","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.neurobiolaging.2016.07.030","volume":"47","author":"SK Soosman","year":"2016","unstructured":"Soosman, S. K. et al. Widespread white matter and conduction defects in PSEN1-related spastic paraparesis. Neurobiol. Aging 47, 201\u2013209 (2016).","journal-title":"Neurobiol. Aging"},{"key":"1359_CR63","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1148\/radiol.2343040197","volume":"234","author":"NA Johnson","year":"2005","unstructured":"Johnson, N. A. et al. Pattern of cerebral hypoperfusion in Alzheimer disease and mild cognitive impairment measured with arterial spin-labeling MR imaging: initial experience. Radiology 234, 851\u2013859 (2005).","journal-title":"Radiology"},{"key":"1359_CR64","doi-asserted-by":"crossref","first-page":"906","DOI":"10.3174\/ajnr.A3780","volume":"35","author":"H Takahashi","year":"2014","unstructured":"Takahashi, H. et al. Clinical application of 3D arterial spin-labeled brain perfusion imaging for Alzheimer disease: comparison with brain perfusion SPECT. AJNR Am. J. Neuroradiol. 35, 906\u2013911 (2014).","journal-title":"AJNR Am. J. Neuroradiol."},{"key":"1359_CR65","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1212\/01.wnl.0000238163.71349.78","volume":"67","author":"AT Du","year":"2006","unstructured":"Du, A. T. et al. Hypoperfusion in frontotemporal dementia and Alzheimer disease by arterial spin labeling MRI. Neurology 67, 1215\u20131220 (2006).","journal-title":"Neurology"},{"key":"1359_CR66","doi-asserted-by":"crossref","first-page":"e4051","DOI":"10.1002\/nbm.4051","volume":"32","author":"Y Li","year":"2019","unstructured":"Li, Y. et al. ASL-MRICloud: an online tool for the processing of ASL MRI data. NMR Biomed. 32, e4051 (2019).","journal-title":"NMR Biomed."},{"key":"1359_CR67","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1212\/WNL.0000000000000721","volume":"83","author":"E McDade","year":"2014","unstructured":"McDade, E. et al. Cerebral perfusion alterations and cerebral amyloid in autosomal dominant Alzheimer disease. Neurology 83, 710\u2013717 (2014).","journal-title":"Neurology"},{"key":"1359_CR68","doi-asserted-by":"crossref","unstructured":"Biswal, B. & Zerrin Yetkin, F. Functional connectivity in the motor cortex of resting human brain using echo\u2010planar MRI. Magn. Reson. Med. 34, 537\u2013541 (1995).","DOI":"10.1002\/mrm.1910340409"},{"key":"1359_CR69","doi-asserted-by":"crossref","first-page":"7709","DOI":"10.1523\/JNEUROSCI.2177-05.2005","volume":"25","author":"RL Buckner","year":"2005","unstructured":"Buckner, R. L. et al. Molecular, structural, and functional characterization of Alzheimer\u2019s disease: evidence for a relationship between default activity, amyloid, and memory. J. Neurosci. 25, 7709\u20137717 (2005).","journal-title":"J. Neurosci."},{"key":"1359_CR70","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S1474-4422(12)70291-0","volume":"12","author":"CR Jack Jr","year":"2013","unstructured":"Jack, C. R. Jr et al. Tracking pathophysiological processes in Alzheimer\u2019s disease: an updated hypothetical model of dynamic biomarkers. Lancet Neurol. 12, 207\u2013216 (2013).","journal-title":"Lancet Neurol."},{"key":"1359_CR71","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.neuroimage.2014.11.058","volume":"107","author":"Y Su","year":"2015","unstructured":"Su, Y. et al. Partial volume correction in quantitative amyloid imaging. Neuroimage 107, 55\u201364 (2015).","journal-title":"Neuroimage"},{"key":"1359_CR72","doi-asserted-by":"crossref","first-page":"e0152082","DOI":"10.1371\/journal.pone.0152082","volume":"11","author":"Y Su","year":"2016","unstructured":"Su, Y. et al. Quantitative amyloid imaging in autosomal dominant Alzheimer\u2019s disease: results from the DIAN Study Group. PLoS ONE 11, e0152082 (2016).","journal-title":"PLoS ONE"},{"key":"1359_CR73","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.nicl.2018.04.022","volume":"19","author":"Y Su","year":"2018","unstructured":"Su, Y. et al. Utilizing the centiloid scale in cross-sectional and longitudinal PiB PET studies. Neuroimage Clin. 19, 406\u2013416 (2018).","journal-title":"Neuroimage Clin."},{"key":"1359_CR74","doi-asserted-by":"crossref","first-page":"1-15.e1","DOI":"10.1016\/j.jalz.2014.07.003","volume":"11","author":"WE Klunk","year":"2015","unstructured":"Klunk, W. E. et al. The Centiloid Project: standardizing quantitative amyloid plaque estimation by PET. Alzheimers Dement. 11, 1-15.e1\u20131-15e4 (2015).","journal-title":"Alzheimers Dement."},{"key":"1359_CR75","doi-asserted-by":"crossref","unstructured":"Buckner, L. B., Head, D., Parker, P., Fotenos, A. F. & Marcus, D. A unified approach for morphometric and functional data analysis in young, old, and demented adults using automated atlas-based head size normalization Neuroimage 23, 724\u2013738 (2004).","DOI":"10.1016\/j.neuroimage.2004.06.018"}],"container-title":["Nature Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41593-023-01359-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41593-023-01359-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41593-023-01359-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,3]],"date-time":"2023-08-03T08:08:30Z","timestamp":1691050110000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41593-023-01359-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,10]]},"references-count":75,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2023,8]]}},"alternative-id":["1359"],"URL":"https:\/\/doi.org\/10.1038\/s41593-023-01359-8","relation":{},"ISSN":["1097-6256","1546-1726"],"issn-type":[{"value":"1097-6256","type":"print"},{"value":"1546-1726","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,10]]},"assertion":[{"value":"10 March 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 May 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 July 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"In addition to the acknowledged granting bodies, the authors of this manuscript have received financial support from Eli Lilly (N.G.R.), Biogen (N.G.R. and C.C.), AbbVie (N.G.R. and J.L.), Eisai (C.R. and C.C.), Cerveau Technologies (C.R.) and Alector (C.C.). Consultations have been declared for Humana Healthcare (J.P.C.), Roche (N.C.F., J.L., C.R., R.S.V. and R.J.B.), Biogen (N.C.F., J.L. and C.R.), Parabon Nanolabs (G.S.D. and C.C.), DynaMed (EBSCO Health) (G.S.D.), medical testimony on legal cases pertaining to management of Wernicke encephalopathy (G.S.D.), MODAG GmbH (J.L.), Bayer Vital (J.L.), Axon Neuroscience (J.L.), Thieme Medical Publishers (J.L.), Prothena (C.R.), Wave Pharmaceuticals (R.S.V.), Janssen (R.S.V.), Neuraxpharm (R.S.V.), Blue Earth Diagnostics (I.Y.), ABX-CRO (I.Y.), ICON plc (I.Y.), Piramal (I.Y.), Eisai (R.J.B.) and Amgen (R.J.B.). Honoraria for lectures from Eisai (T.I.), Saiichi-Sankyo (T.I.), Ajinomoto (T.I.), Novartis (T.I.), Chugai (T.I.), Takeda (T.I.), Blue Earth Diagnostics (I.Y.), ABX-CRO (I.Y.), ICON plc (I.Y.) and Piramal (I.Y.). Other financial interests include owning stocks greater than $10,000 held in ANI Pharmaceuticals (G.S.D.), having a patent for PiB-PET technology (W.K.), being a member of the DIAN-TU Pharma Consortium, which includes funding and non-financial support for the DIAN-TU-001 trial from Avid Radiopharmaceuticals, Janssen, Hoffman Roche\/Genentech, Eli Lilly, Eisai, Biogen, AbbVie and Bristol Myers Squibb (R.J.B. and T.L.S.B.) and royalties from C2N Diagnostics with equity ownership interest (R.J.B.). All other authors have nothing to disclose.Non-financial interests include serving on an independent data monitoring board for Roche (C.R.J.), support from Eli Lilly (N.C.F.), support from Ionis (N.C.F.), serving as director of Anti-NMDA Receptor Encephalitis Foundation (G.S.D.), member of the advisory board of Vivid Genetics (C.C.), member of the advisory board of Halia Therapeutics (C.C.), member of the advisory boards of ADx Healthcare (C.C.), Eisai (T.L.S.B.), Siemens (T.L.S.B) and a member of speaker\u2019s bureau for Biogen (T.L.S.B.).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}